Evolutec Group PLC
10 February 2006
Evolutec Group plc (the 'Company')
Holding in Company
The Company received notification on 9 February 2006 that, following a increase
in its total holding of shares, AXA S.A. is interested in 3,496,407 ordinary
shares of 10 pence each representing 14.82 per cent. of the Company's issued
share capital ('Ordinary Shares'). This interest comprises a beneficial interest
of 42,650 shares and a non-beneficial interest of 3,453,757 shares.
The shares are registered as follows:
Name of the Company/Fund Particulars of the Registered as Interest
Beneficial Owners
Sun Life Pensions Management Sun Life Pensions Smith & Williamson Nominees Ltd 30,000
Ltd (Beneficial) Management Ltd
Sun Life Pensions Management Sun Life Pensions BNY (OCS) Nominees Limited 12,650
Ltd (Beneficial) Management Ltd
Framlington HSBC HSBC Global Custody HSBC Global Custody Nominees (UK) 2,789,507
(Non-Beneficial) Nominees (UK) Limited Limited
Framlington BBH Noms BBH Nominees Not Disclosed 331,250
(Non-Beneficial)
Framlington SSB Noms State Street Nominees Not Disclosed 218,000
(Non-Beneficial)
Framlington BONY OCS BONY (OCS) Not Disclosed 115,000
(Non-Beneficial)
Total 3,496,407
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.